[Read More] Ng FM, Sun J, Sharma L, Libinaka R, Jiang WJ, Gianello R
In certain scenarios, autophagy or autophagy-related proteins may paradoxically promote cellular apoptosis or necrosis
Although these drugs are FDA-approved to treat specific conditions, such as obesity or type 2 diabetes, research studies for potential additional uses and conditions, beyond obesity and diabetes, are underway
One unit, one protocol
Jancova P, Anzenbacher P, Anzenbacherova E
This workshop offers a unique opportunity to: Understand the latest regulatory thinking on generic GLP-1 product development Learn about cutting-edge analytical and formulation approaches for peptide products Gain insights into device design, human factors, and combination product development Network with peers and experts in the field Explore real-world case examples and best practices Participate in collaborative discussions on emerging challenges Join us to be part of the conversation shaping the future of generic GLP-1 product development